Most people think peptides = injections. Full stop.

And for years, that was basically true. You reconstitute your vial, load the syringe, pinch some belly fat, and get on with your day. That's the protocol. That's the culture.

But there's a second administration route that doesn't get nearly enough attention, and for a specific category of peptides, it might actually be the superior option.

We're talking about nasal sprays. And no, this isn't some watered-down alternative for people afraid of needles. This is real pharmacology with a legitimate mechanism that changes how certain peptides reach your brain.

Let me explain.

Why intranasal works differently than you think

When you inject a peptide subcutaneously, it enters systemic circulation and travels through the bloodstream. That works perfectly for recovery peptides, growth hormone secretagogues, and most of what's in your protocol stack.

But here's the issue: the blood-brain barrier. It's exactly what it sounds like. A highly selective filter that blocks most compounds from crossing into the central nervous system. For peptides targeting the brain, injecting into your abdomen is taking a detour when there's a shortcut sitting right in front of you.

The olfactory pathway bypasses all of that.

The nasal cavity has a direct neuroanatomical connection to the brain through the olfactory nerve. Small peptides delivered intranasally can travel this route and reach CNS tissue without needing to cross the blood-brain barrier at all. That's not a workaround. That's the intended mechanism, and it's exactly why the original Russian research on Semax and Selank was conducted almost exclusively via nasal administration.

This is the reason intranasal exists as a serious route, not a convenient one.

Where injection still wins

For systemic effects, injection is not going anywhere. Bioavailability through the nasal mucosa is lower and more variable than a clean sub-Q shot. You also run into size limitations. Larger peptides simply don't absorb well intranasally. The molecular weight is too high for the mucosa to handle efficiently.

Here's how it breaks down practically:

BPC-157 for systemic recovery? Sub-Q. BPC-157 specifically for gut healing? Oral suspension actually makes more sense because you want local action in the GI tract, not systemic circulation.

CJC-1295 and Ipamorelin? Injection only. These are too large for intranasal to be effective. Same with TB-500 and Tesamorelin. The peptide size makes the nasal route a non-starter.

Semax and Selank? Intranasal every time. These were designed for this route. The nose-to-brain pathway is the whole point. Injecting them intramuscularly isn't wrong, but you're working against the mechanism.

PT-141? Originally developed as a nasal spray. It works both ways, but intranasal has a long track record.

Epithalon? Both routes are used. Most experienced users prefer injection, but intranasal is a legitimate option especially for people who don't want daily needles for a longevity protocol.

The practical stuff nobody tells you

Nasal administration sounds simple until it isn't. A few things worth knowing:

Formulation matters more than people realize. The pH of the solution, the concentration, and whether a proper preservative is used all affect how much actually absorbs. A poorly formulated nasal spray can have absorption that's all over the place, which makes dialing in your dosing genuinely difficult.

Congestion is a real variable. If your sinuses are inflamed or you're sick, your absorption that day is compromised. Something to factor in if you're running a strict protocol.

Shelf life once reconstituted is generally shorter than injectable vials stored properly in the fridge. Not a dealbreaker, but something to plan around.

And the needle-avoidance argument is valid. Compliance matters. A person who consistently uses a nasal spray is going to get better results than someone who skips injections because they hate the process. If intranasal works for the peptide you're using, there's nothing wrong with choosing the route you'll actually stick to.

The real framework

Neuro and cognitive peptides: intranasal is typically the preferred or purpose-built route.

Systemic recovery, body composition, and GH axis peptides: injection wins every time on bioavailability and consistency.

Gut-targeted BPC-157: oral is the exception that makes sense.

The question isn't which route is better in a vacuum. The question is which route fits the peptide's mechanism and your actual life. Match the administration method to the goal, not the other way around.

As always, source matters regardless of how you're administering. A nasal spray made from an impure peptide doesn't become safer because it bypasses the gut. COA verification is non-negotiable no matter what route you choose.

Until next time, keep asking the questions most people are too lazy to look up.

Lee

P.S. Roxy doesn't care which administration route we're discussing. She just wanted me awake at 4 AM for it.

1. Nose-to-Brain Drug Delivery Illum, L. (2004). Nasal drug delivery: new developments and strategies. Drug Discovery Today. https://www.sciencedirect.com/science/article/pii/S1359644603029903

2. Intranasal Peptide Bioavailability and the Olfactory Pathway Dhuria, S.V., Hanson, L.R., & Frey, W.H. (2010). Intranasal delivery to the central nervous system. Journal of Pharmaceutical Sciences. https://www.sciencedirect.com/science/article/pii/S0022354915328197

3. Semax Neuroprotective Effects via Intranasal Administration Dolotov, O.V. et al. (2006). Semax, an analog of ACTH 4-10, regulates BDNF and trkB expression in the rat brain. Journal of Neurochemistry. https://pubmed.ncbi.nlm.nih.gov/16704726/

4. BPC-157 Systemic vs. Local Administration Outcomes Sikiric, P. et al. (2018). Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design. https://pubmed.ncbi.nlm.nih.gov/30317990/

5. Subcutaneous vs. Intranasal Peptide Absorption Comparison Pires, A., Fortuna, A., Alves, G., & Falcão, A. (2009). Intranasal drug delivery: how, why and what for? Journal of Pharmacy and Pharmaceutical Sciences. https://pubmed.ncbi.nlm.nih.gov/19555625/